iShares U.S. Pharmaceuticals ETF (IHE) — ()
Key Metrics
News
IHE: Healthcare Dashboard For June
Published: by:
Sentiment: Positive ()
The healthcare providers industry is undervalued by about 22% versus 11-year averages, while pharma/biotech and life science tools trade near historical baseline in valuation. IHE ETF offers exposure to U.S. …
Read More
ETFs on the Move Post U.S.-China Trade Deal
Published: by:
Sentiment: Positive ()
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Read More
Pharma ETFs in Focus on Trump's Drug Price Overhaul
Published: by:
Sentiment: Negative ()
Trump's plan to slash the price of prescription drugs by 30% put pharma ETFs in focus.
Read More
A Look at Pharma ETFs After Strong Q1 Earnings
Published: by:
Sentiment: Positive ()
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Read More
About iShares U.S. Pharmaceuticals ETF IHE
The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.